Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Prufeta | M | - |
Rejuvitas, Inc.
 Rejuvitas, Inc. BiotechnologyHealth Technology Rejuvitas, Inc. provides biotechnology services. The company is based in Nissequogue, NY. The company was founded by Andrea Spezzi. Andrea Spezzi has been the CEO since incorporation.
Medical Excellence Capital LLC
 Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City.
ProJenX, Inc.
 ProJenX, Inc. Miscellaneous Commercial ServicesCommercial Services ProJenX, Inc. is a clinical-stage biotechnology company that focuses on developing targeted therapies for untreatable brain diseases, with a particular emphasis on ALS. The company is based in Nissequogue, NY. ProJenX's lead therapy candidate, Prosetin, is a first-in-class kinase inhibitor that is being developed for people living with ALS. The company's innovative, patient-specific, cell-based drug discovery platform is at the heart of its approach to research and drug development for ALS and other debilitating brain diseases. The company was founded in 2021 by Erin Fleming and Valerie Estess, and the CEO is Stan E. Abel. | 4 years |
| Brian Halak | M | 52 |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City.
Nobias Therapeutics, Inc.
 Nobias Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nobias Therapeutics, Inc. develops drugs to cure rare illnesses in children. The American company was founded by Brian K. Halak. | 4 years |
| Andrea Spezzi | M | - |
Rejuvitas, Inc.
Rejuvitas, Inc. BiotechnologyHealth Technology Rejuvitas, Inc. provides biotechnology services. The company is based in Nissequogue, NY. The company was founded by Andrea Spezzi. Andrea Spezzi has been the CEO since incorporation. | 3 years |
| Stanley Abel | M | - |
ProJenX, Inc.
ProJenX, Inc. Miscellaneous Commercial ServicesCommercial Services ProJenX, Inc. is a clinical-stage biotechnology company that focuses on developing targeted therapies for untreatable brain diseases, with a particular emphasis on ALS. The company is based in Nissequogue, NY. ProJenX's lead therapy candidate, Prosetin, is a first-in-class kinase inhibitor that is being developed for people living with ALS. The company's innovative, patient-specific, cell-based drug discovery platform is at the heart of its approach to research and drug development for ALS and other debilitating brain diseases. The company was founded in 2021 by Erin Fleming and Valerie Estess, and the CEO is Stan E. Abel. | - |
| Erin Fleming | M | - |
ProJenX, Inc.
ProJenX, Inc. Miscellaneous Commercial ServicesCommercial Services ProJenX, Inc. is a clinical-stage biotechnology company that focuses on developing targeted therapies for untreatable brain diseases, with a particular emphasis on ALS. The company is based in Nissequogue, NY. ProJenX's lead therapy candidate, Prosetin, is a first-in-class kinase inhibitor that is being developed for people living with ALS. The company's innovative, patient-specific, cell-based drug discovery platform is at the heart of its approach to research and drug development for ALS and other debilitating brain diseases. The company was founded in 2021 by Erin Fleming and Valerie Estess, and the CEO is Stan E. Abel. | - |
| Tracy S. Warren | F | - |
Astarte Medical Partners, Inc.
 Astarte Medical Partners, Inc. Packaged SoftwareTechnology Services Astarte Medical Partners develops a software that provides infant health care. It combines research, microbiome data, and innovative software to optimize care and significantly improve outcomes, initially for nation’s tiniest and highest risk patient. The company was founded by Tracy Warren, Tammi Jantzen, and Katherine Gregory and is headquartered in Yardley, PA. | 8 years |
| Tammi Jantzen | F | - |
Astarte Medical Partners, Inc.
Astarte Medical Partners, Inc. Packaged SoftwareTechnology Services Astarte Medical Partners develops a software that provides infant health care. It combines research, microbiome data, and innovative software to optimize care and significantly improve outcomes, initially for nation’s tiniest and highest risk patient. The company was founded by Tracy Warren, Tammi Jantzen, and Katherine Gregory and is headquartered in Yardley, PA. | 8 years |
| Valerie Estess | F | - |
ProJenX, Inc.
ProJenX, Inc. Miscellaneous Commercial ServicesCommercial Services ProJenX, Inc. is a clinical-stage biotechnology company that focuses on developing targeted therapies for untreatable brain diseases, with a particular emphasis on ALS. The company is based in Nissequogue, NY. ProJenX's lead therapy candidate, Prosetin, is a first-in-class kinase inhibitor that is being developed for people living with ALS. The company's innovative, patient-specific, cell-based drug discovery platform is at the heart of its approach to research and drug development for ALS and other debilitating brain diseases. The company was founded in 2021 by Erin Fleming and Valerie Estess, and the CEO is Stan E. Abel. | - |
| Vera King Farris | M | 87 |
University of Pennsylvania
| 21 years |
| JONI MANCINI | F | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | 3 years |
| Hynek Wichterle | M | - |
ProJenX, Inc.
ProJenX, Inc. Miscellaneous Commercial ServicesCommercial Services ProJenX, Inc. is a clinical-stage biotechnology company that focuses on developing targeted therapies for untreatable brain diseases, with a particular emphasis on ALS. The company is based in Nissequogue, NY. ProJenX's lead therapy candidate, Prosetin, is a first-in-class kinase inhibitor that is being developed for people living with ALS. The company's innovative, patient-specific, cell-based drug discovery platform is at the heart of its approach to research and drug development for ALS and other debilitating brain diseases. The company was founded in 2021 by Erin Fleming and Valerie Estess, and the CEO is Stan E. Abel. | - |
| Douglas C Wallace | M | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | - |
| John P Hornbostel | M | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | 3 years |
| Wendy Slatery | F | - |
Astarte Medical Partners, Inc.
Astarte Medical Partners, Inc. Packaged SoftwareTechnology Services Astarte Medical Partners develops a software that provides infant health care. It combines research, microbiome data, and innovative software to optimize care and significantly improve outcomes, initially for nation’s tiniest and highest risk patient. The company was founded by Tracy Warren, Tammi Jantzen, and Katherine Gregory and is headquartered in Yardley, PA. | - |
| Gregg L Semenza | M | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | - |
| Stephen Tsang | M | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | - |
| Euan Ashley | M | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | - |
| Giulia Kennedy | M | 64 |
Astarte Medical Partners, Inc.
Astarte Medical Partners, Inc. Packaged SoftwareTechnology Services Astarte Medical Partners develops a software that provides infant health care. It combines research, microbiome data, and innovative software to optimize care and significantly improve outcomes, initially for nation’s tiniest and highest risk patient. The company was founded by Tracy Warren, Tammi Jantzen, and Katherine Gregory and is headquartered in Yardley, PA. | 5 years |
| Stephen C. Hanson | M | 72 |
Astarte Medical Partners, Inc.
Astarte Medical Partners, Inc. Packaged SoftwareTechnology Services Astarte Medical Partners develops a software that provides infant health care. It combines research, microbiome data, and innovative software to optimize care and significantly improve outcomes, initially for nation’s tiniest and highest risk patient. The company was founded by Tracy Warren, Tammi Jantzen, and Katherine Gregory and is headquartered in Yardley, PA. | - |
| Kim Kamdar | M | 56 |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | 3 years |
| Olga Troyanskaya | M | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jordan Moelis | M | - |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 6 years |
| Jennifer Rowland | F | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Shirin Bohra | F | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Emily Janvey | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Malcolm Dorson | M | - |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 7 years |
| Vandit D. Shah | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| David Bard | M | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Adam Kornfield | M | - |
Lehigh University
| 5 years |
| Virgilio Aquino | M | 40 |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 7 years |
| Damian Dalla-Longa | M | 39 |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 6 years |
| Sapna Tejwani Jethwa | F | - |
The Wharton School of the University of Pennsylvania
| 11 years |
| Kevin Karpuk | M | - |
Lehigh University
| 5 years |
| Samir Malik | M | - |
The Wharton School of the University of Pennsylvania
| 7 years |
| Eli Simon | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Pranav Gupta | M | - |
The Wharton School of the University of Pennsylvania
| 13 years |
| Ryan David Wood | M | - |
Lehigh University
| 5 years |
| Andrea Tulcin | F | - |
Lehigh University
The Wharton School of the University of Pennsylvania
| 7 years |
| Sydney Werber | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Puja Dhanraj | F | - |
University of Pennsylvania
| 5 years |
| Gerson R. Guzman | M | - |
University of Pennsylvania
| 2 years |
| Eric Sun | M | - |
The Wharton School of the University of Pennsylvania
| 11 years |
| Taran Sang Yong Bae | M | - |
University of Pennsylvania
| 2 years |
| Xiaohan Zhu | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Curtis MacDonald | M | - |
Lehigh University
| 5 years |
| Rashad Rahman | M | - |
The Wharton School of the University of Pennsylvania
| 15 years |
| Mohaimin Altaf | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Anthony Nemoto | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Bianca Stoica | F | 31 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Christian Moore | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andre Levy | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Griffin Dann | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Boris Treskunov | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Kelly Zhou | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jacob Benatar | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Ami Naik | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Gregory Dabrowski | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Katie Fullalove | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Ki Chul Cho | M | 46 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Anjana Harve | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| David Poss | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Peter Sullivan | M | 35 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Ekansh Kumar | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeremy Grant | M | 36 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Olivia McKelway | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Daniel Miller | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Thomas Colligan | M | 79 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Daniel Urgelles | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Rohan Shilotri | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Joe Dekker | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Melissa Louise Claugus | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Sean M. Korduner | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Joel Hwang | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Charles H. Tingue | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Noran Eid | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Sam Ensslin | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Alina Costica DiMeglio | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Frank Robinson | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Matthew A. Speaker | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jared Herzikoff-Cornell | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Christina Zhang | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Ryan Feit | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Hunter Horsley | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| David Roberts | M | 40 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Di Cai | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Joshua Salzman | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Zack Yang | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jared Lee Marks | M | 35 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Peter Maa | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| Edward Chung | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Andrew Fohrer | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Liam Localio | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Brooks Powlen | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| Christopher Wynn | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Joseph Stein | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Tyra Junaid | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Justin Johnson Scott | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Nicholas John Nottebohm | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Ji Zhang | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Tami Zakaria | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Heil
- Personal Network
